Pure Powdered Caffeine: Stakeholders Take Measure of FDA’s Warning Label
‘Pure Powdered Caffeine: Stakeholders Take Measure of FDA’s Warning Label,’ contribution by Rend Al-Mondhiry, FDLI’s Food and Drug Policy Forum, February 2016.
On August 27, 2015, the US Food and Drug Administration (FDA) issued Warning Letters to five companies selling pure powdered bulk caffeine to consumers as a dietary supplement. Participants in this issue of Policy Forum were asked if they believed FDA was justified in issuing the Warning Letters on pure powdered caffeine and, more broadly, to address FDA’s and their own roles in assuring the safety of dietary supplement products on the market.
Read the Compendium here.
